Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells.

Dabiri Y, Abu El Maaty MA, Chan HY, Wölker J, Ott I, Wölfl S, Cheng X.

Front Oncol. 2019 May 29;9:438. doi: 10.3389/fonc.2019.00438. eCollection 2019.

2.

In vitro metabolic activation of vitamin D3 by using a multi-compartment microfluidic liver-kidney organ on chip platform.

Theobald J, Abu El Maaty MA, Kusterer N, Wetterauer B, Wink M, Cheng X, Wölfl S.

Sci Rep. 2019 Mar 15;9(1):4616. doi: 10.1038/s41598-019-40851-9.

3.

Activation of pro-survival metabolic networks by 1,25(OH)2D3 does not hamper the sensitivity of breast cancer cells to chemotherapeutics.

Abu El Maaty MA, Dabiri Y, Almouhanna F, Blagojevic B, Theobald J, Büttner M, Wölfl S.

Cancer Metab. 2018 Aug 30;6:11. doi: 10.1186/s40170-018-0183-6. eCollection 2018.

4.

Expression of TXNIP in Cancer Cells and Regulation by 1,25(OH)₂D₃: Is It Really the Vitamin D₃ Upregulated Protein?

Abu El Maaty MA, Almouhanna F, Wölfl S.

Int J Mol Sci. 2018 Mar 10;19(3). pii: E796. doi: 10.3390/ijms19030796.

5.

Vitamin D as a Novel Regulator of Tumor Metabolism: Insights on Potential Mechanisms and Implications for Anti-Cancer Therapy.

Abu El Maaty MA, Wölfl S.

Int J Mol Sci. 2017 Oct 19;18(10). pii: E2184. doi: 10.3390/ijms18102184. Review.

6.

1,25(OH)2D3 disrupts glucose metabolism in prostate cancer cells leading to a truncation of the TCA cycle and inhibition of TXNIP expression.

Abu El Maaty MA, Alborzinia H, Khan SJ, Büttner M, Wölfl S.

Biochim Biophys Acta Mol Cell Res. 2017 Oct;1864(10):1618-1630. doi: 10.1016/j.bbamcr.2017.06.019. Epub 2017 Jun 23.

7.

Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.

Abu El Maaty MA, Strassburger W, Qaiser T, Dabiri Y, Wölfl S.

Mol Carcinog. 2017 Nov;56(11):2486-2498. doi: 10.1002/mc.22696. Epub 2017 Jul 13.

PMID:
28618116
8.

Effects of 1,25(OH)₂D₃ on Cancer Cells and Potential Applications in Combination with Established and Putative Anti-Cancer Agents.

Abu El Maaty MA, Wölfl S.

Nutrients. 2017 Jan 23;9(1). pii: E87. doi: 10.3390/nu9010087. Review.

9.

A multi-target caffeine derived rhodium(i) N-heterocyclic carbene complex: evaluation of the mechanism of action.

Zhang JJ, Muenzner JK, Abu El Maaty MA, Karge B, Schobert R, Wölfl S, Ott I.

Dalton Trans. 2016 Aug 16;45(33):13161-8. doi: 10.1039/c6dt02025a.

PMID:
27334935
10.

Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex.

Andermark V, Göke K, Kokoschka M, Abu El Maaty MA, Lum CT, Zou T, Sun RW, Aguiló E, Oehninger L, Rodríguez L, Bunjes H, Wölfl S, Che CM, Ott I.

J Inorg Biochem. 2016 Jul;160:140-8. doi: 10.1016/j.jinorgbio.2015.12.020. Epub 2015 Dec 30.

PMID:
26850306
11.

Genetic variation in vitamin D receptor gene (Fok1:rs2228570) is associated with risk of coronary artery disease.

Abu El Maaty MA, Hassanein SI, Gad MZ.

Biomarkers. 2016;21(1):68-72. doi: 10.3109/1354750X.2015.1118535. Epub 2015 Dec 8.

PMID:
26643870
12.

Vitamin D receptor gene polymorphisms (TaqI and ApaI) in relation to 25-hydroxyvitamin D levels and coronary artery disease incidence.

Abu el Maaty MA, Hassanein SI, Sleem HM, Gad MZ.

J Recept Signal Transduct Res. 2015;35(5):391-5. doi: 10.3109/10799893.2014.959593. Epub 2014 Sep 16.

PMID:
25224407
13.

Investigating the cardio-protective abilities of supplemental L-arginine on parameters of endothelial function in a hypercholesterolemic animal model.

Gad MZ, Abu el Maaty MA, El-Maraghy SA, Fahim AT, Hamdy MA.

J Nutr Sci Vitaminol (Tokyo). 2014;60(3):145-51.

14.

Triangular relationship between single nucleotide polymorphisms in the CYP2R1 gene (rs10741657 and rs12794714), 25-hydroxyvitamin d levels, and coronary artery disease incidence.

Hassanein SI, Abu El Maaty MA, Sleem HM, Gad MZ.

Biomarkers. 2014 Sep;19(6):488-92. doi: 10.3109/1354750X.2014.939226. Epub 2014 Jul 8.

PMID:
25003556
15.

Effect of polymorphisms in the NADSYN1/DHCR7 locus (rs12785878 and rs1790349) on plasma 25-hydroxyvitamin D levels and coronary artery disease incidence.

Abu El Maaty MA, Hassanein SI, Sleem HM, Gad MZ.

J Nutrigenet Nutrigenomics. 2013;6(6):327-35. doi: 10.1159/000360422. Epub 2014 Mar 15.

PMID:
24642724
16.

Vitamin D deficiency and cardiovascular disease: potential mechanisms and novel perspectives.

Abu el Maaty MA, Gad MZ.

J Nutr Sci Vitaminol (Tokyo). 2013;59(6):479-88. Review.

17.

Interplay of vitamin D and nitric oxide in post-menopausal knee osteoarthritis.

Abu El Maaty MA, Hanafi RS, El-Badawy S, Gad MZ.

Aging Clin Exp Res. 2014 Aug;26(4):363-8. doi: 10.1007/s40520-013-0192-9. Epub 2013 Dec 29.

PMID:
24374888
18.
19.

Association of suboptimal 25-hydroxyvitamin D levels with knee osteoarthritis incidence in post-menopausal Egyptian women.

Abu el Maaty MA, Hanafi RS, El Badawy S, Gad MZ.

Rheumatol Int. 2013 Nov;33(11):2903-7. doi: 10.1007/s00296-012-2551-9. Epub 2012 Nov 4.

PMID:
23124694

Supplemental Content

Loading ...
Support Center